Haemonetics study shows VASCADE MVP XL posts 1.2% vascular complications in 1,623 large-bore electrophysiology cases

Reuters2026/08/03 20:24

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Haemonetics disclosed publication of a new retrospective study supporting VASCADE MVP XL use in large-bore venous access electrophysiology procedures.
Results have already been published, adding real-world evidence from the largest reported patient cohort for the device to date.
The study found the system delivered fast vessel closure, supported same-day discharge, and showed a favorable safety profile without surgical interventions.
The findings reinforce the device’s expanded US labeling cleared in March 2026 for use with larger procedural sheaths in electrophysiology cases.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Haemonetics Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: 202608031615PR_NEWS_USPR_____NE17673) on August 03, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Haemonetics study shows VASCADE MVP XL posts 1.2% vascular complications in 1,623 large-bore electrophysiology cases

You may also like

Crypto prices